<DOC>
	<DOCNO>NCT00872261</DOCNO>
	<brief_summary>This study examine characteristic behavior young woman India Tanzania determine challenge opportunity exist conduct future trial HIV prevention treatment .</brief_summary>
	<brief_title>Determining Characteristics Behaviors Adolescent Women Regarding HIV Risk Microbicide Trial Participation</brief_title>
	<detailed_description>HIV infection damage person 's immune system develop AIDS . More 10 million woman age 15 24 currently live HIV AIDS , sub-Saharan Africa Asia . The rate infection woman high part may able use exist HIV prevention method : remain abstinent help partner also abstinent use male condom require compliance male . Oral topical microbicides product woman initiate use reduce risk HIV infection . Several clinical trial product conduct , test population young woman , may different characteristic behavior woman . This study collect data characteristic behavior woman divide two age group , woman age 15 17 woman age 18 21 , Tanzania India . This study four goal : ( 1 ) determine whether characteristic put woman risk HIV differ age country group ; ( 2 ) evaluate legal , social , cultural , delivery factor hinder woman 's participation microbicide trial ; ( 3 ) examine understand ability woman different group adhere requirement clinical trial participation ; ( 4 ) determine young woman 's acceptability use practice gel pill . This study consist three phase . The first phase address first two goal conduct repeat , in-depth interview discussion small group sexually active adolescent India Tanzania , follow interviews informant relevant community member . These interview discussion address difference HIV risk characteristic group woman legal , social , cultural , delivery factor hinder woman 's participation microbicide trial . The second phase consist series workshops define describe set youth-friendly procedure use microbicides . Community member researcher participate workshop , adolescent invite pretest study instrument . The third phase pilot clinical study address second two goal ask participant undergo evaluation time , similar way would microbicide trial . Participants complete study visit baseline 2 , 4 , 6 month , time answer question sexual relationship use risk reduction behavior . They also provide urine , blood , endo-cervical swab sample test pregnancy , HIV , sexually transmit infection . Between 4- 6-month visit , participant also ask participate 2-month substudy use proxy pill gel . They complete interview experience use pill gel . Some participant decline participate invited complete brief interview choose participate .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Sexually active 3 month prior screen Willing provide biological sample answer question sexual behavior Pregnancy HIV infect</criteria>
	<gender>Female</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Clinical Trials Topic</keyword>
	<keyword>Adolescent Psychology</keyword>
	<keyword>Patient Acceptance Health Care</keyword>
	<keyword>HIV Risk Behaviors</keyword>
	<keyword>Adolescents</keyword>
	<keyword>Clinical Trial Recruitment</keyword>
	<keyword>Microbicide Acceptability</keyword>
	<keyword>Ethics</keyword>
	<keyword>Mixed Methods</keyword>
	<keyword>HIV</keyword>
</DOC>